Trial | NCT01113528  Report issue

Title

Omega-3 and Aspirin in Periodontal Regeneration
The Effect of Host Response Modulation Therapy (Omega 3 Plus Low-dose Aspirin) as an Adjunctive Treatment of Chronic Periodontitis (Clinical and Biochemical Study)

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    40
To evaluate the efficacy of systemic administration of omega 3 PUFA plus low dose aspirin as an adjunctive therapy to regenerative modality of grade II furcation defects in periodontitis patients.
In this study, we tested the hypothesis that the administration of omega 3 PUFA plus low dose aspirin would augment the results following regenerative therapy of furcation defects in chronic periodontitis patients.
Study Started
Nov 30
2009
Primary Completion
Dec 31
2009
Study Completion
May 31
2010
Last Update
May 14
2010
Estimate

Other Regenerative therapy (omega 3 PUFA plus low dose aspirin)

Comparison between regenerative bone graft alone and bone graft + Omega-3 and low dose aspirin

  • Other names: Omega, Fish oil, ASA, low dose aspirin, DFDBA

Drug Sugar pill

3 times daily

  • Other names: Gelatinous capsules

Regenerative therapy Experimental

Sugar pill Placebo Comparator

Criteria 

Inclusion Criteria:

suffering moderate to sever chronic periodontitis and displaying at least a single grade II furcation defect according to Glickman's classification 1953, determined by both clinical and radiographic examinations;
free from systemic diseases known to influence the periodontal condition and not receiving any medication known to affect the periodontal status;
have not receive any periodontal therapy for a minimum of 6 months prior to the study.

Exclusion Criteria:

Known hypersensitivity or allergy to one of the used medications
Pregnancy or lactation
Heavy smoking (more than 10cigarretes/day)
History of alcohol abuse
Participation in other clinical trials
No Results Posted